ARL3 is downregulated and acts as a prognostic biomarker in glioma

by Yulin Wang, Weijiang Zhao, Xin Liu, Gefei Guan, Minghua Zhuang
Published 2019-06-01

A Risk Classification System With Five-Gene for Survival Prediction of Glioblastoma Patients

by Yulin Wang, Xin Liu, Gefei Guan, Weijiang Zhao, Minghua Zhuang
Published 2019-07-01

LOXL2 Upregulation in Gliomas Drives Tumorigenicity by Activating Autophagy to Promote TMZ Resistance and Trigger EMT

by Qing Zhang, Lianhe Yang, Gefei Guan, Peng Cheng, Wen Cheng, Anhua Wu
Published 2020-10-01

Identification of a Five-Pseudogene Signature for Predicting Survival and Its ceRNA Network in Glioma

by Yulin Wang, Xin Liu, Gefei Guan, Zhe Xiao, Weijiang Zhao, Weijiang Zhao, Minghua Zhuang
Published 2019-10-01

Profiling pro-neural to mesenchymal transition identifies a lncRNA signature in glioma

by Qingyu Liang, Gefei Guan, Xue Li, Chunmi Wei, Jianqi Wu, Peng Cheng, Anhua Wu, Wen Cheng
Published 2020-10-01

ARL2 overexpression inhibits glioma proliferation and tumorigenicity via down-regulating AXL

by Yulin Wang, Gefei Guan, Wen Cheng, Yang Jiang, Fengping Shan, Anhua Wu, Peng Cheng, Zongze Guo
Published 2018-05-01

(2-Hydroxypropyl)-β-Cyclodextrin Is a New Angiogenic Molecule for Therapeutic Angiogenesis.

by Xun Qi, Yonghui Yuan, Ke Xu, Hongshan Zhong, Zhen Zhang, Huan Zhai, Gefei Guan, Guibo Yu
Published 2015-01-01

Development and validation of an interferon signature predicting prognosis and treatment response for glioblastoma

by Chen Zhu, Cunyi Zou, Gefei Guan, Qing Guo, Zihao Yan, Tianqi Liu, Shuai Shen, Xiaoyan Xu, Chen Chen, Zhiguo Lin, Wen Cheng, Anhua Wu
Published 2019-09-01

Characterization of ROS Metabolic Equilibrium Reclassifies Pan-Cancer Samples and Guides Pathway Targeting Therapy

by Shuai Shen, Zihao Yan, Jianqi Wu, Xing Liu, Gefei Guan, Cunyi Zou, Qing Guo, Chen Zhu, Tianqi Liu, Chen Chen, Ling Chen, Peng Cheng, Wen Cheng, Anhua Wu
Published 2020-10-01